|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61M 5/315 | (2006.01) |
| A61M 5/31511 | (2013.01) | ||
| A61M 5/31541 | (2013.01) | ||
| A61M 5/31551 | (2013.01) | ||
| A61M 5/31558 | (2013.01) | ||
| A61M 5/31575 | (2013.01) | ||
| A61M 5/31585 | (2013.01) | ||
| A61M2005/2407 | (2013.01) | ||
| A61M2005/2488 | (2013.01) | ||
| A61M2005/2492 | (2013.01) | ||
| A61M2005/3152 | (2013.01) | ||
| A61M 5/31543 | (2013.01) |
| (11) | Patento numeris | 2529774 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12165097.2 |
| Europos patento paraiškos padavimo data | 2010-05-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-12-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-08-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 182820 P | 2009-06-01 | US | |
| 09009057 | 2009-07-10 | EP |
| (72) |
Plumptre, David Aubrey , GB
Jones, Christopher John , GB
|
| (73) |
Sanofi-Aventis Deutschland GmbH ,
Brüningstraße 50, 65929 Frankfurt am Main,
DE
|
| (54) | Resetting mechanism for a drug delivery device |
| Resetting mechanism for a drug delivery device |